125 related articles for article (PubMed ID: 1537861)
21. The mouse extracellular signal-regulated kinase 2 gene. Gene structure and characterization of the promoter.
Sugiura N; Suga T; Ozeki Y; Mamiya G; Takishima K
J Biol Chem; 1997 Aug; 272(34):21575-81. PubMed ID: 9261178
[TBL] [Abstract][Full Text] [Related]
22. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
[TBL] [Abstract][Full Text] [Related]
23. Genetic mapping of the gene for a novel tyrosine kinase, Blk, to mouse chromosome 14.
Kozak CA; Dymecki SM; Niederhuber JE; Desiderio SV
Genomics; 1991 Apr; 9(4):762-4. PubMed ID: 2037301
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement.
Wasserman R; Li YS; Hardy RR
J Immunol; 1995 Jul; 155(2):644-51. PubMed ID: 7608542
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells.
Aoki Y; Isselbacher KJ; Cherayil BJ; Pillai S
Proc Natl Acad Sci U S A; 1994 May; 91(10):4204-8. PubMed ID: 7514299
[TBL] [Abstract][Full Text] [Related]
26. The murine gene for cellular retinoic acid-binding protein type II. Genomic organization, chromosomal localization, and post-transcriptional regulation by retinoic acid.
MacGregor TM; Copeland NG; Jenkins NA; Giguère V
J Biol Chem; 1992 Apr; 267(11):7777-83. PubMed ID: 1313808
[TBL] [Abstract][Full Text] [Related]
27. The mouse p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1) gene. Genomic organization and structure of the 5'-flanking regulatory region.
Pagès G; Stanley ER; Le Gall M; Brunet A; Pouysségur J
J Biol Chem; 1995 Nov; 270(45):26986-92. PubMed ID: 7592946
[TBL] [Abstract][Full Text] [Related]
28. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.
Tretter T; Ross AE; Dordai DI; Desiderio S
J Exp Med; 2003 Dec; 198(12):1863-73. PubMed ID: 14662906
[TBL] [Abstract][Full Text] [Related]
29. Structure of the murine fifth complement component (C5) gene. A large, highly interrupted gene with a variant donor splice site and organizational homology with the third and fourth complement component genes.
Haviland DL; Haviland JC; Fleischer DT; Wetsel RA
J Biol Chem; 1991 Jun; 266(18):11818-25. PubMed ID: 1711041
[TBL] [Abstract][Full Text] [Related]
30. The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors.
Miglarese MR; Mannion-Henderson J; Wu H; Parsons JT; Bender TP
Oncogene; 1994 Jul; 9(7):1989-97. PubMed ID: 7516062
[TBL] [Abstract][Full Text] [Related]
31. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases.
Burkhardt AL; Brunswick M; Bolen JB; Mond JJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7410-4. PubMed ID: 1714601
[TBL] [Abstract][Full Text] [Related]
32. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo.
Yang W; Malek SN; Desiderio S
J Biol Chem; 1995 Sep; 270(35):20832-40. PubMed ID: 7657668
[TBL] [Abstract][Full Text] [Related]
33. AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter.
Libermann TA; Pan Z; Akbarali Y; Hetherington CJ; Boltax J; Yergeau DA; Zhang DE
J Biol Chem; 1999 Aug; 274(35):24671-6. PubMed ID: 10455134
[TBL] [Abstract][Full Text] [Related]
34. Structure and expression of the mouse growth hormone receptor/growth hormone binding protein gene.
Moffat JG; Edens A; Talamantes F
J Mol Endocrinol; 1999 Aug; 23(1):33-44. PubMed ID: 10425445
[TBL] [Abstract][Full Text] [Related]
35. Organization and analysis of the promoter region and 5' non-coding exons of the human c-src proto-oncogene.
Bonham K; Fujita DJ
Oncogene; 1993 Jul; 8(7):1973-81. PubMed ID: 8510939
[TBL] [Abstract][Full Text] [Related]
36. Structure of the mouse pore-forming protein (perforin) gene: analysis of transcription initiation site, 5' flanking sequence, and alternative splicing of 5' untranslated regions.
Youn BS; Liu CC; Kim KK; Young JD; Kwon MH; Kwon BS
J Exp Med; 1991 Apr; 173(4):813-22. PubMed ID: 1840607
[TBL] [Abstract][Full Text] [Related]
37. Reconstitution of the B cell antigen receptor signaling components in COS cells.
Saouaf SJ; Kut SA; Fargnoli J; Rowley RB; Bolen JB; Mahajan S
J Biol Chem; 1995 Nov; 270(45):27072-8. PubMed ID: 7592958
[TBL] [Abstract][Full Text] [Related]
38. Genomic organization and expression of the human alpha 1B-adrenergic receptor.
Ramarao CS; Denker JM; Perez DM; Gaivin RJ; Riek RP; Graham RM
J Biol Chem; 1992 Oct; 267(30):21936-45. PubMed ID: 1328250
[TBL] [Abstract][Full Text] [Related]
39. A novel BLK-induced tumor model.
Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
[TBL] [Abstract][Full Text] [Related]
40. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
